Skip to content

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00749970
Acronym
SWN-K
Enrollment
100
Registered
2008-09-10
Start date
2008-07-31
Completion date
2009-01-31
Last updated
2010-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizoaffective Disorder, Schizophrenia, Schizophreniform Disorder

Keywords

schizophrenia, subjective well-being, psychometric validation

Brief summary

Observational, short-term prospective, multicenter study to assess psychometric properties of the Spanish version of SWN-K scale in patients with schizophrenia.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder (DSM-IV TR criteria) * Stabilized out-patients * Under treatment with an oral antipsychotic drug

Exclusion criteria

* Administration of a depot antipsychotic drug * Participation in another clinical trial within 4 weeks prior to enrolment into this study

Design outcomes

Primary

MeasureTime frame
SWN-K7 days
PANSS7 days

Secondary

MeasureTime frame
CGI-I7 days

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026